Resolution Statement – 29364-20 Ireland v express.co.uk
Summary of Complaint
1. Rebecca Ireland complained to the Independent Press
Standards Organisation that express.co.uk breached Clause 1 of the Editors’
Code of Practice in an article headlined “How Brexit helped Britain approve
coronavirus vaccine - Thank God we're leaving!”, published on 2 December 2020.
2. The article, which only appeared online, focused on the
approval of the Pfizer Covid-19 vaccine. It reported on comments by Jacob
Rees-Mogg MP, who said the “quick” approval of the vaccination was “only
possible due to Britain's momentous Brexit decision.” It went on to say that Mr
Rees-Mogg’s “sentiment was echoed by Health Secretary Matt Hancock, who said
"because of Brexit" the vaccine had under[gone] "all the same
safety checks and the same processes" but "not at the pace of the
Europeans who are moving a little bit more slowly.””
3. The complainant said that the article was inaccurate in
breach of Clause 1. The headline of the article said, without qualification or
attribution, that “Brexit helped Britain approve” the vaccine, and the article
itself did not contradict this claim. The complainant said that this was
inaccurate as the vaccination had been approved prior to the UK leaving the
European Union, and within the EU’s existing regulatory framework.
4. The publication said it accepted that the headline was
misleading, as it did not attribute the headline claim to Mr Rees-Mogg. One
week after the article’s original publication, it amended the headline to make
clear that the claim was the opinion of Mr Rees-Mogg; the updated headline read
“Rees-Mogg says coronavirus vaccine victory is due to quitting EU.” The
publication also added the following footnote clarification to the bottom of
the article:
CLARIFICATION: A previous version of this article was
headlined: 'How Brexit helped Britain approve coronavirus vaccine - Thank God
we're leaving!' The headline has since been amended to make clear that these
were in fact the views of Jacob Rees-Mogg. We are happy to clarify these were
comments from Jacob Rees-Mogg.
5. The complainant said that, while she appreciated the
steps that the publication had taken to address her concerns, the action
offered by the publication was not sufficient to resolve her complaint. She
said that the position of the clarification, at the bottom of the article, was
not sufficiently prominent, and also asked that the clarification be reworded
to make clear that it was inaccurate to state that “Brexit helped Britain approve
[the] coronavirus vaccine.”
6. The publication amended the article to move the
clarification to the top of the article, directly beneath the headline. It
declined to amend the wording of the clarification, as it considered it
sufficient to correct the disputed point of accuracy identified by the
complainant, and that it had been published with due promptness and prominence.
7. The complainant said that she still did not consider the
action taken by the publication to be sufficient to address her concerns and
wished for IPSO to investigate the matter.
Relevant Code Provisions
8. Clause 1 (Accuracy)
i) The Press must take care not to publish inaccurate, misleading or distorted information or images, including headlines not supported by the text.
ii) A significant inaccuracy, misleading statement or
distortion must be corrected, promptly and with due prominence, and — where
appropriate — an apology published. In cases involving IPSO, due prominence
should be as required by the regulator.
iii) A fair opportunity to reply to significant inaccuracies
should be given, when reasonably called for.
iv) The Press, while free to editorialise and campaign, must
distinguish clearly between comment, conjecture and fact.
Mediated Outcome
9. The complaint was not resolved through direct
correspondence between the parties. IPSO therefore began an investigation into
the matter.
10. The publication removed the article from its website. It
also published the following wording as a standalone online correction, under
the headline “Brexit coronavirus vaccine article - A Correction”:
“Our article 'How Brexit helped Britain approve coronavirus
vaccine - Thank God we're leaving!' reported the comments of Jacob Rees-Mogg
and Matt Hancock that Brexit helped us get the vaccine more quickly. However,
it has subsequently been pointed out by the chief executive of the MHRA, that
Matt Hancock was wrong to say that the UK could approve the vaccine early
because it was no longer subject to EU rules. The MHRA's decision was taken in
accordance with the relevant EU legislation, which allows member states to
grant temporary authorisation for a medicinal product in response to the spread
of infectious diseases. This legislation still applies to the UK until the end
of the transition period. Any EU member state could have used the same
provision of the legislation to approve the vaccine. We are happy to clarify
that they decided not to for political and technical reasons, not legal ones.”
11. The complainant said that this would resolve the matter
to her satisfaction.
12. As the complaint was successfully mediated, the
Complaints Committee did not make a determination as to whether there had been
any breach of the Code.
Date complaint received: 03/12/2020
Date complaint concluded by IPSO: 18/03/2021
Back to ruling listing